Research Article
Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
Table 4
The results of ROC analysis of FDG uptake metrics for breast lymphoma versus breast carcinoma.
| Variable | Lymphoma | Carcinoma | Pa value | AUC | Pb value | Median | Range | Median | Range |
| SUVmin | 0.80 | 0.12–2.84 | 0.96 | 0.35–1.77 | 0.971 | 0.437 | 0.379 | SUVmean | 4.75 | 1.03–17.02 | 2.38 | 0.79–8.29 | <0.001 | 0.747 | 0.001 | SUVstd | 2.04 | 0.33–12.30 | 0.88 | 0.15–3.61 | 0.001 | 0.755 | <0.001 | SUVmax | 10.69 | 2.10–43.21 | 4.76 | 1.05–18.43 | 0.001 | 0.747 | 0.001 | SUVpeak | 9.15 | 0.00–40.65 | 2.78 | 0.00–16.33 | <0.001 | 0.749 | <0.001 | TLG | 42.24 | 2.24–4031.99 | 9.90 | 0.55–2240.40 | 0.001 | 0.754 | <0.001 |
|
|
Note. Pa refers to the significance for ROC curves, Pb is for Mann–Whitney U tests between breast lymphoma and breast carcinoma.
|